336 related articles for article (PubMed ID: 12808169)
1. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
Tumlin JA; Lohavichan V; Hennigar R
Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
[TBL] [Abstract][Full Text] [Related]
2. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
Tumlin JA; Hennigar RA
Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530
[TBL] [Abstract][Full Text] [Related]
3. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
4. Combination of pulse cyclophosphamide and steroids in crescentic IgA nephropathy.
Ramachandran R; Doddi P; Nandakrishna B; Nada R; Kumar V; Rathi M; Kohli HS; Jha V; Sakhuja V; Gupta KL
Int Urol Nephrol; 2015 Nov; 47(11):1917-8. PubMed ID: 26411427
[No Abstract] [Full Text] [Related]
5. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
Jiang XY; Mo Y; Sun LZ; Yue ZH; Chen SM; Wu W
Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
Rasche FM; Klotz CH; Czock D; Karges W; Muche R; Jehle PM; Mertz A; Keller F
Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
[TBL] [Abstract][Full Text] [Related]
7. Steroid and cyclophosphamide in IgA nephropathy.
Roccatello D; Ferro M; Cesano G; Rossi D; Berutti S; Salomone M; Piccoli G; Sena LM
Nephrol Dial Transplant; 2000 Jun; 15(6):833-5. PubMed ID: 10831636
[TBL] [Abstract][Full Text] [Related]
8. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of crescentic IgA nephropathy after renal transplantation.
Zagkotsis G; Vourlakou C; Paraskevopoulos A; Apostolou T
CEN Case Rep; 2018 Nov; 7(2):268-273. PubMed ID: 29802527
[TBL] [Abstract][Full Text] [Related]
10. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
11. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy.
Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G
Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy.
Kawasaki Y; Hosoya M; Suzuki J; Onishi N; Takahashi A; Isome M; Nozawa R; Suzuki H
Am J Nephrol; 2004; 24(6):576-81. PubMed ID: 15550753
[TBL] [Abstract][Full Text] [Related]
13. Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide.
Mitsuiki K; Harada A; Okura T; Higaki J
Clin Exp Nephrol; 2007 Dec; 11(4):297-303. PubMed ID: 18085391
[TBL] [Abstract][Full Text] [Related]
14. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
15. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
[TBL] [Abstract][Full Text] [Related]
17. Treatment of IgA nephropathy of adults presented by nephrotic syndrome.
Rasić S; Uncanin S; Aganović K; Rasić I; Dzemidzić J; Muslimović A
Bosn J Basic Med Sci; 2008 Aug; 8(3):230-3. PubMed ID: 18816254
[TBL] [Abstract][Full Text] [Related]
18. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
19. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
[TBL] [Abstract][Full Text] [Related]
20. Intravenous "pulse" cyclophosphamide therapy of crescentic glomerulonephritis.
Kunis CL; Kiss B; Williams G; D'Agati V; Appel GB
Clin Nephrol; 1992 Jan; 37(1):1-7. PubMed ID: 1541058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]